Search research articles
Contact Us
Filters
Showing results (11-20 of 39) with videos related to
Page
of 4
Sort By:
Molecular Pharmacology
|
October 1, 1986
Solid state conformations and antidopaminergic effects of remoxipride hydrochloride and a closely related salicylamide, FLA 797, in relation to dopamine receptor models
T Högberg, S Rämsby, T de Paulis, et al.
Brain Research
|
October 20, 1999
Pharmacological characterization of morphine-6-sulfate and codeine-6-sulfate
A Zuckerman, E Bolan, T de Paulis, et al.
Journal of Medicinal Chemistry
|
October 1, 1988
(S)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-[125I]iodo- 2-methoxybenzamide hydrochloride, a new selective radioligand for dopamine D-2 receptors
T de Paulis, A Janowsky, R M Kessler, et al.
Journal of Medicinal Chemistry
|
August 1, 1990
Potential antipsychotic agents. 7. Synthesis and antidopaminergic properties of the atypical highly potent (S)-5-bromo-2,3-dimethoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl]benzamide and related compounds. A comparative study
T Högberg, T de Paulis, L Johansson, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 1, 1992
Extrastriatal dopamine D2 receptors: distribution, pharmacological characterization and region-specific regulation by clozapine
A Janowsky, K A Neve, J M Kinzie, et al.
Journal of Medicinal Chemistry
|
April 1, 1990
Potential antipsychotic agents 5. Synthesis and antidopaminergic properties of substituted 5,6-dimethoxysalicylamides and related compounds
T Högberg, S Bengtsson, T de Paulis, et al.
Journal of Medicinal Chemistry
|
September 1, 1981
Synthesis of clozapine analogues and their affinity for clozapine and spiroperidol binding sites in rat brain
T de Paulis, C R Betts, H E Smith, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
June 3, 1998
Characterization of desamino-5-[125I]iodo-3-methoxy-zacopride ([125I]MIZAC) binding to 5-HT3 receptors in the rat brain
W A Hewlett, S Fridman, B L Trivedi, et al.
European Journal of Pharmacology
|
May 20, 1988
[125I]iodopride: a specific high affinity radioligand for labelling striatal dopamine D-2 receptors
A Janowsky, T De Paulis, J A Clanton, et al.
Acta Pharmaceutica Suecica
|
January 1, 1975
Antidepressant agents. IV. Phenylcycloaklylamines
B Carnmalm, T De Paulis, E Jacupovic, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 39) with videos related to
Sort By:
Page
of 4
Molecular Pharmacology
|
October 1, 1986
Solid state conformations and antidopaminergic effects of remoxipride hydrochloride and a closely related salicylamide, FLA 797, in relation to dopamine receptor models
T Högberg, S Rämsby, T de Paulis, et al.
Brain Research
|
October 20, 1999
Pharmacological characterization of morphine-6-sulfate and codeine-6-sulfate
A Zuckerman, E Bolan, T de Paulis, et al.
Journal of Medicinal Chemistry
|
October 1, 1988
(S)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-[125I]iodo- 2-methoxybenzamide hydrochloride, a new selective radioligand for dopamine D-2 receptors
T de Paulis, A Janowsky, R M Kessler, et al.
Journal of Medicinal Chemistry
|
August 1, 1990
Potential antipsychotic agents. 7. Synthesis and antidopaminergic properties of the atypical highly potent (S)-5-bromo-2,3-dimethoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl]benzamide and related compounds. A comparative study
T Högberg, T de Paulis, L Johansson, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 1, 1992
Extrastriatal dopamine D2 receptors: distribution, pharmacological characterization and region-specific regulation by clozapine
A Janowsky, K A Neve, J M Kinzie, et al.
Journal of Medicinal Chemistry
|
April 1, 1990
Potential antipsychotic agents 5. Synthesis and antidopaminergic properties of substituted 5,6-dimethoxysalicylamides and related compounds
T Högberg, S Bengtsson, T de Paulis, et al.
Journal of Medicinal Chemistry
|
September 1, 1981
Synthesis of clozapine analogues and their affinity for clozapine and spiroperidol binding sites in rat brain
T de Paulis, C R Betts, H E Smith, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
June 3, 1998
Characterization of desamino-5-[125I]iodo-3-methoxy-zacopride ([125I]MIZAC) binding to 5-HT3 receptors in the rat brain
W A Hewlett, S Fridman, B L Trivedi, et al.
European Journal of Pharmacology
|
May 20, 1988
[125I]iodopride: a specific high affinity radioligand for labelling striatal dopamine D-2 receptors
A Janowsky, T De Paulis, J A Clanton, et al.
Acta Pharmaceutica Suecica
|
January 1, 1975
Antidepressant agents. IV. Phenylcycloaklylamines
B Carnmalm, T De Paulis, E Jacupovic, et al.
Page
of 4